Write an Essay on topic - Poverty can be eliminated by putting science at the heart of development
Answers
Answered by
2
We want to end extreme poverty.
If you’re reading this, we’re pretty sure
that you do as well. You will probably
already know about the enormous
progress being made – that between
1990 and 2015, the global under-five
death rate, the malaria death rate, and
the number of people living in extreme
poverty
all halved.
If we are going to end extreme poverty,
it’s going to take more than additional
funds or deeper commitment, however.
We are going to have to put science at
the heart of international development.
That’s why the Department for
International Development
(DfID) and the Bill & Melinda Gates
Foundation have signed a partnership
aimed at using research, technological
innovation and knowledge-sharing to
transform the lives of the poorest
people.
We believe that science should go not
only to improving the lives of those who
can afford it, but also to those with the
greatest need, regardless of where they
are.
This investment isn’t just altruistic.
As we saw from the Ebola outbreak , and
again with Zika, many so-called
diseases of the poor don’t just affect
people in distant lands: they ignore
class and background, and strike when
we are least prepared.
So why has the need not been met
already?
In spite of the clear moral and public
health rationale for R&D, the profit
motive is less clear. The market, on its
own, finds it hard enough to invest in
high-reward, low-risk ventures, never
mind those where the patient is an Aids
orphan or a person with tuberculosis.
Correcting this problem with the market
has, however, been a fundamental role
for the state for generations. As anyone
who has ever watched the TV series
Longitude knows, philanthropic and
state capital had to provide the
incentives to develop a way of
measuring longitude. Publicly funded
research helped create the internet and
microprocessors. It led to the
discoveries of penicillin and monoclonal
antibodies , which revolutionised
medicine. And it fostered a green
revolution that saved hundreds of
millions of people from starvation.
In all those cases the state, and to a
lesser extent philanthropists, recognised
the huge rewards to society as a whole.
Today, we believe that the governments
and philanthropists of the developed
world have a similar role to play in
correcting market failures that mean the
public goods needed most are not being
developed.
The Gates Foundation invests more than
£350m a year in global health research
and has invested more than £370m in
agricultural R&D since 2008. DfID
spends over £80m a year on global
health research and a further £80m on
agriculture R&D.
When we pool resources we can have a
greater impact.
One example is the global alliance for
livestock veterinary medicines
, a partnership we have co-funded since
2008. Among its successes has been
an East Coast fever vaccine distribution
network in Kenya, Uganda, Tanzania
and Malawi. This disease is the biggest
killer of cattle in 11 countries in sub-
Saharan Africa, where livestock is a
critical asset. Over 1.4m doses have
been sold, saving approximately $100m
worth of livestock.
The medicines for malaria venture
(MMV) develops new drugs and we
have supported it since its inception in
2002. MMV has launched six new
treatments including Coartem®
Dispersible, which was the first
developed specifically to treat young
children. Since its launch in 2009, more
than 300m treatments have been
delivered in more than 50 countries.
Much of our joint innovation will take
place in British labs. With world-class
universities, scientists and innovators,
the UK is a global leader in the R&D that
improves the health and well-being of
the poorest people. That leadership
creates jobs in the UK, and leads to
growth and scientific breakthroughs that
fuel other areas of industry and
development.
We also aim to help spur the
development of scientific knowledge in
Africa. Working with the Wellcome
Trust, we have been helping to develop
the alliance for accelerating excellence
in science in Africa
. We also support crop and livestock
scientists from 18 African countries so
that they can access cutting-edge
facilities at the Biosciences for eastern
and central Africa hub
in Nairobi, Kenya.
Through our continued investment in
these global public goods, we are
confident that we will be able to improve
the lives not only of the poorest, but of
all of us.
If you’re reading this, we’re pretty sure
that you do as well. You will probably
already know about the enormous
progress being made – that between
1990 and 2015, the global under-five
death rate, the malaria death rate, and
the number of people living in extreme
poverty
all halved.
If we are going to end extreme poverty,
it’s going to take more than additional
funds or deeper commitment, however.
We are going to have to put science at
the heart of international development.
That’s why the Department for
International Development
(DfID) and the Bill & Melinda Gates
Foundation have signed a partnership
aimed at using research, technological
innovation and knowledge-sharing to
transform the lives of the poorest
people.
We believe that science should go not
only to improving the lives of those who
can afford it, but also to those with the
greatest need, regardless of where they
are.
This investment isn’t just altruistic.
As we saw from the Ebola outbreak , and
again with Zika, many so-called
diseases of the poor don’t just affect
people in distant lands: they ignore
class and background, and strike when
we are least prepared.
So why has the need not been met
already?
In spite of the clear moral and public
health rationale for R&D, the profit
motive is less clear. The market, on its
own, finds it hard enough to invest in
high-reward, low-risk ventures, never
mind those where the patient is an Aids
orphan or a person with tuberculosis.
Correcting this problem with the market
has, however, been a fundamental role
for the state for generations. As anyone
who has ever watched the TV series
Longitude knows, philanthropic and
state capital had to provide the
incentives to develop a way of
measuring longitude. Publicly funded
research helped create the internet and
microprocessors. It led to the
discoveries of penicillin and monoclonal
antibodies , which revolutionised
medicine. And it fostered a green
revolution that saved hundreds of
millions of people from starvation.
In all those cases the state, and to a
lesser extent philanthropists, recognised
the huge rewards to society as a whole.
Today, we believe that the governments
and philanthropists of the developed
world have a similar role to play in
correcting market failures that mean the
public goods needed most are not being
developed.
The Gates Foundation invests more than
£350m a year in global health research
and has invested more than £370m in
agricultural R&D since 2008. DfID
spends over £80m a year on global
health research and a further £80m on
agriculture R&D.
When we pool resources we can have a
greater impact.
One example is the global alliance for
livestock veterinary medicines
, a partnership we have co-funded since
2008. Among its successes has been
an East Coast fever vaccine distribution
network in Kenya, Uganda, Tanzania
and Malawi. This disease is the biggest
killer of cattle in 11 countries in sub-
Saharan Africa, where livestock is a
critical asset. Over 1.4m doses have
been sold, saving approximately $100m
worth of livestock.
The medicines for malaria venture
(MMV) develops new drugs and we
have supported it since its inception in
2002. MMV has launched six new
treatments including Coartem®
Dispersible, which was the first
developed specifically to treat young
children. Since its launch in 2009, more
than 300m treatments have been
delivered in more than 50 countries.
Much of our joint innovation will take
place in British labs. With world-class
universities, scientists and innovators,
the UK is a global leader in the R&D that
improves the health and well-being of
the poorest people. That leadership
creates jobs in the UK, and leads to
growth and scientific breakthroughs that
fuel other areas of industry and
development.
We also aim to help spur the
development of scientific knowledge in
Africa. Working with the Wellcome
Trust, we have been helping to develop
the alliance for accelerating excellence
in science in Africa
. We also support crop and livestock
scientists from 18 African countries so
that they can access cutting-edge
facilities at the Biosciences for eastern
and central Africa hub
in Nairobi, Kenya.
Through our continued investment in
these global public goods, we are
confident that we will be able to improve
the lives not only of the poorest, but of
all of us.
Answered by
0
We want to end extreme poverty.
You will probably already know about the enormous progress being made – that between 1990 and 2015, the global under-five death rate, the malaria death rate, and the number of people living in extreme poverty all halved.
If we are going to end extreme poverty, it’s going to take more than additional funds or deeper commitment, however. We are going to have to put science at the heart of international development.
That’s why the Department for International Development (DfID) and the Bill & Melinda Gates Foundation have signed a partnership aimed at using research, technological innovation and knowledge-sharing to transform the lives of the poorest people.
We believe that science should go not only to improving the lives of those who can afford it, but also to those with the greatest need, regardless of where they are.
This investment isn’t just altruistic.
hope it helps
pls mark as brainliest
#be brainly
Similar questions